Published Date: 17 Mar 2023
The American College of Rheumatology (ACR) and the American College of Hip Surgery (AAHKS) have released new guidelines.
Read Full NewsThe CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.
The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.
1.
Which Risk Model Better Identifies High-Risk Smoldering MM?
2.
Study offers clearer picture of childhood brain tumor survival
3.
US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry
4.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
5.
An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.
1.
Exploring the Latest Treatments for Desmoid Tumors
2.
Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment
3.
The Millionaire's Battle: Does Mark Cuban Have Cancer?
4.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
5.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation